EMILY HUXFORD: Open Payments
NPI 1780301895 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 63 payments from 16 companies in 2025. Trend: 2023 $409 · 2024 $464 · 2025 $1,288
Food & beverage: $1,271Education: $17
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 7 | $258 |
| AstraZeneca Pharmaceuticals LP | 4 | $176 |
| OPKO Pharmaceuticals, LLC | 10 | $162 |
| Travere Therapeutics, Inc. | 13 | $102 |
| Calliditas Therapeutics US Inc. | 4 | $98 |
| Ardelyx, Inc. | 4 | $79 |
| ANI Pharmaceuticals, Inc. | 3 | $63 |
| Vifor Pharma, Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
Products named: Vafseo, RAYALDEE, LOKELMA, TARPEYO, IBSRELA, PURIFIED CORTROPHIN GEL, Veltassa, JARDIANCE.
Industry payments across MO — which companies pay providers there.
